Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sub-anesthetic esketamine for prevention of postoperative catheter-related bladder discomfort after ureteroscopic litholapaxy
ChiCTR2300076262Phase 4Completed
- Sponsor
- Peking University Shenzhen Hospital
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine in cystitis (3 arms), sponsored by Peking University Shenzhen Hospital. Primary endpoint: Incidence of moderate to severe catheter-related bladder discomfort at 0 hours postoperatively. Started Oct 2023; status: completed.
02
Drugs
esketamine
03
Conditions
cystitis
Beyond the preview
Go deeper on ChiCTR2300076262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076262.